TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employee. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) is a pharmaceutical product for the treatment of moderate-to-severe dyspareunia. BIJUVA is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA is a one-year, ring-shaped contraceptive vaginal system (CVS).
Follow-Up Questions
What is the price performance of TXMD stock?
The current price of TXMD is $1.08, it has decreased 0% in the last trading day.
What are the primary business themes or industries for TherapeuticsMD Inc?
TherapeuticsMD Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is TherapeuticsMD Inc market cap?
TherapeuticsMD Inc's current market cap is $12.4M
Is TherapeuticsMD Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for TherapeuticsMD Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell
